Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Superiority of insulin glargine (Lantus) versus NPH: Treat to normoglycemia
2007-006640-22Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of insulin glargine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Sanofi. Primary endpoint: Change in HbA1c from baseline to end of treatment. Started Jul 2008; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-006640-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006640-22.